FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+10.53%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$1.05B
AUM Growth
+$1.05B
(-13%)
Cap. Flow
-$86.5M
Cap. Flow
% of AUM
-8.27%
Top 10 Holdings %
Top 10 Hldgs %
60.57%
Holding
47
New
9
Increased
9
Reduced
18
Closed
11
Top Buys
| 1 |
Twist Bioscience
TWST
|
$57M |
| 2 |
iRhythm Technologies
IRTC
|
$38.8M |
| 3 |
MiMedx Group
MDXG
|
$32.2M |
| 4 |
Vera Therapeutics
VERA
|
$23.5M |
| 5 |
Edgewise Therapeutics
EWTX
|
$20.8M |
Top Sells
| 1 |
Insulet
PODD
|
$32.7M |
| 2 |
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
|
$31.5M |
| 3 |
Tandem Diabetes Care
TNDM
|
$26.4M |
| 4 |
Evolent Health
EVH
|
$25.3M |
| 5 |
BCYC
Bicycle Therapeutics
BCYC
|
$21.9M |
Sector Composition
| 1 | Healthcare | 99.64% |
| 2 | Technology | 0.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FNA
1
DELISTED
Paragon 28, Inc.
FNA
| $109M | 10.46% | 10,580,467 +425,824 | +4% | +$4.4M |
|
|
CNTA
2
Centessa Pharmaceuticals
CNTA
$2.25B
| $97.2M | 9.3% | 5,805,184 -134,948 | -2% | -$2.26M |
|
3
Axogen
AXGN
$743M
| $74.3M | 7.11% | 4,506,795 +416,499 | +10% | +$6.86M |
|
4
AtriCure
ATRC
$1.84B
| $60.2M | 5.76% | 1,969,221 +103,685 | +6% | +$3.17M |
|
|
5
Twist Bioscience
TWST
$1.63B
| $57M | 5.45% | +1,226,255 | New | +$57M |
|
|
6
Vera Therapeutics
VERA
$1.38B
| $53.3M | 5.1% | 1,261,246 +556,012 | +79% | +$23.5M |
|
7
NeoGenomics
NEO
$1.13B
| $52.2M | 4.99% | 3,167,585 +91,030 | +3% | +$1.5M |
|
8
Xenon Pharmaceuticals
XENE
$2.98B
| $45.5M | 4.35% | 1,160,580 -21,082 | -2% | -$826K |
|
9
Crinetics Pharmaceuticals
CRNX
$2.92B
| $45.3M | 4.33% | 885,453 -58,158 | -6% | -$2.97M |
|
|
10
iRhythm Technologies
IRTC
$5.46B
| $38.8M | 3.71% | +430,500 | New | +$38.8M |
|
11
Health Catalyst
HCAT
$239M
| $37.1M | 3.55% | 5,241,121 +944,631 | +22% | +$6.68M |
|
|
PHLT
12
Performant Healthcare, Inc. Common Stock
PHLT
$603M
| $34.3M | 3.28% | 11,346,649 +136,249 | +1% | +$411K |
|
13
Insmed
INSM
$28.8B
| $32.5M | 3.11% | 470,192 -218,718 | -32% | -$15.1M |
|
|
14
MiMedx Group
MDXG
$1.05B
| $32.2M | 3.08% | +3,343,861 | New | +$32.2M |
|
15
Ultragenyx Pharmaceutical
RARE
$2.89B
| $32.1M | 3.07% | 763,607 +8,505 | +1% | +$358K |
|
16
KORU Medical Systems
KRMD
$195M
| $22.8M | 2.18% | 5,915,434 +316,509 | +6% | +$1.22M |
|
17
Pliant Therapeutics
PLRX
$101M
| $22.1M | 2.12% | 1,681,110 -894,436 | -35% | -$11.8M |
|
|
18
Edgewise Therapeutics
EWTX
$1.51B
| $20.8M | 1.99% | +780,639 | New | +$20.8M |
|
19
Janux Therapeutics
JANX
$1.37B
| $16.8M | 1.61% | +313,782 | New | +$16.8M |
|
20
SI-BONE Inc
SIBN
$719M
| $15.9M | 1.53% | 1,136,982 -389,233 | -26% | -$5.46M |
|
21
Kymera Therapeutics
KYMR
$2.95B
| $15.4M | 1.48% | 383,310 -23,038 | -6% | -$927K |
|
22
Natera
NTRA
$23.1B
| $14.7M | 1.41% | 93,088 -91,851 | -50% | -$14.5M |
|
23
Butterfly Network
BFLY
$405M
| $12.5M | 1.19% | +3,994,620 | New | +$12.5M |
|
24
Repligen
RGEN
$6.88B
| $11.9M | 1.14% | 82,455 -83,418 | -50% | -$12M |
|
25
AnaptysBio
ANAB
$569M
| $11.5M | 1.1% | 868,882 -79,249 | -8% | -$1.05M |
|